Segicef T 250mg/31.25mg Injection
Marketer
Selaginella Life Sciences
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Segicef T 250mg/31.25mg Injection
Cefixime and Sulbactam injection (250mg/31.25mg), sold as Segicef T, combats bacterial infections by inhibiting microbial growth. Administer this combination medication strictly as directed by a physician. Complete the prescribed course, even with symptom improvement; premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Report worsening side effects or allergic reactions (rash, itching, swelling, breathing difficulties) immediately. Inform your doctor about all other medications before using Segicef T. Pregnant or lactating individuals should seek medical advice prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if experiencing drowsiness or dizziness. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your doctor may order tests to monitor the medication's impact.
Uses of Segicef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Segicef T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Segicef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Segicef T 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Segicef T 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Segicef T 250mg/31.25mg Injection, offer a powerful antibacterial approach. Ceftriaxone's antibiotic action disrupts bacterial cell wall synthesis, hindering their growth and survival. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Segicef T 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefixime/Sulbactam 250mg/31.25mg injection is typically deemed safe for pregnancy. Preclinical trials in animals revealed minimal or no harm to fetuses; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Segicef T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Segicef T 250mg/31.25mg Injection could induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Segicef T 250mg/31.25mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
The injectable medication, Segicef T 250mg/31.25mg, requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Segicef T 250mg/31.25mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Segicef T 250mg/31.25mg Injection :
Omit doses of Segicef T 250mg/31.25mg Injection only after physician consultation.
Facts to Know About Segicef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently